Tinea capitis.

L Y Matsuoka; P Gedz

Home/Archive/PubMed

PubMed · 7055022

Tinea capitis.

L Y Matsuoka·P Gedz

View original source ↗Export metadata ↓

Abstract

Trichophyton tonsurans is now a major cause of tinea capitis, affecting both children and adults. The characteristic lesions are pruritic, scaling patches with black dots; Wood's light examination is negative. Microsporum canis and Microsporum audouini, formerly the most frequent causes of tinea capitis, predominantly affect children and are Wood's light positive. Lesions caused by M. canis are inflammatory, while those of M. audouini are scaly. All three organisms respond to griseofulvin.

Explore related subjects

Administration, Oral Adult Child Dermatomycoses Griseofulvin Humans Light Microsporum Tinea Capitis Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

L Y Matsuoka, P Gedz. 1982. Tinea capitis.. https://pubmed.ncbi.nlm.nih.gov/7055022/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

Oral ganciclovir for cytomegalovirus retinitis.

Explore the source record for details and available documents.

Administration, Oral↗

PubMed1996

Oral ganciclovir for cytomegalovirus retinitis.

Explore the source record for details and available documents.

Administration, Oral↗

PubMed1996

A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence.

PURPOSE: We evaluated the efficacy and safety of yohimbine and isoxsuprine or pentoxifylline in the management of vasculogenic erectile dysfunction. MATERIALS AND METHODS: A total of 20 patients diagnosed with arterial insufficiency and cavernous venous leakage by pharmacological penile duplex scanning underwent nonhormonal oral therapy. A randomized crossover study was performed using 5.4 mg. yohimbine plus 10 mg. isoxsuprine or 400 mg. pentoxifylline 3 times daily. Response to therapy was assessed by a sexual questionnaire and repeat penile duplex ultrasonography. RESULTS: No patient in either phase of the study in either group had a complete response to the oral regimen(s) and there was no improvement in the pre-injection or post-injection cavernous arterial peak systolic flow velocities or resistance indexes. CONCLUSIONS: Our study suggests that these oral agents, although well tolerated, were not effective in the management of these patients with mixed vasculogenic erectile dysfunction.

Administration, Oral↗